Lopid Patent Term Restoration and Fairness Act of 1987: Hearing Before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, One Hundredth Congress, First Session, October 8, 1987, Volume 4U.S. Government Printing Office, 1988 - 350 pages |
From inside the book
Results 1-5 of 89
Page 34
... mean average time of evaluation is about two years or 24 months . So there has been some information brought to my attention of the concern of the regulatory process on both sides , but they are very different applications and have very ...
... mean average time of evaluation is about two years or 24 months . So there has been some information brought to my attention of the concern of the regulatory process on both sides , but they are very different applications and have very ...
Page 62
... mean decreases . Patent # 3,674,836 issued covering Lopid ( gemfibrozil ) ( the " Lopid Patent " ) . A series of Lopid clinical studies launched in the United States and overseas . Studies range from 16 to 48 weeks ( average 28 weeks ) ...
... mean decreases . Patent # 3,674,836 issued covering Lopid ( gemfibrozil ) ( the " Lopid Patent " ) . A series of Lopid clinical studies launched in the United States and overseas . Studies range from 16 to 48 weeks ( average 28 weeks ) ...
Page 88
... means , without written permission from the publishers . This publication is copyright under the Berne Convention and the International Copyright Convention . All rights reserved . Apart from any fair dealing under the UK Copyright Act ...
... means , without written permission from the publishers . This publication is copyright under the Berne Convention and the International Copyright Convention . All rights reserved . Apart from any fair dealing under the UK Copyright Act ...
Page 94
... ( mean age 60 years ; range 46-76 ) and four females ( mean age 68 years ; range 62-78 ) were investigated in an open study , during and after cessation of gemfibrozil treatment . All patients had been on gemfibrozil ( 600 mg twice daily ) ...
... ( mean age 60 years ; range 46-76 ) and four females ( mean age 68 years ; range 62-78 ) were investigated in an open study , during and after cessation of gemfibrozil treatment . All patients had been on gemfibrozil ( 600 mg twice daily ) ...
Page 95
... Means and standard errors of the mean were calculated by ordinary methods . The effect of the treatment has been tested for each variable using a three - way and a four- way analysis of variance model ( Lindman 1974 ) . In the three ...
... Means and standard errors of the mean were calculated by ordinary methods . The effect of the treatment has been tested for each variable using a three - way and a four- way analysis of variance model ( Lindman 1974 ) . In the three ...
Other editions - View all
Common terms and phrases
apolipoprotein Association atherosclerosis baseline bill blood Capsules cardiovascular cent Chairman changes cholesterol cholesterol levels cholestyramine clofibrate Committee concentrations coronary heart disease decrease diabetic diet dose Drug Administration dyslipidaemic effect of gemfibrozil elevated fatty acid composition FDA approval Finland follow-up Food and Drug Framingham gemfibrozil treatment glucose HDL-cholesterol Health heart attacks Helsinki Heart Study hypercholesterolaemia hypertension incidence increase ischaemic heart disease Journal KASTENMEIER Kaukola laboratory legislation lipid lowering Lipid Research Clinics lipid-lowering lipoprotein cholesterol lipoprotein lipase lipoprotein lipase activity Lithell long-term Lopid Lopid patent low density lipoprotein LRC-CPPT male Manninen market exclusivity metabolism mmol/l mortality myocardial infarction Parke-Davis patent extension patent term extension patients pharmaceutical Phase IV study placebo Primary Prevention Trial ratio reduction regulatory risk factors Royal Society safety serum cholesterol serum lipid significant Society of Medicine Subcommittee Table Term Restoration Act therapy treatment groups triglycerides Vessby VLDL Warner-Lambert Waxman-Hatch
Popular passages
Page 113 - A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity, J.
Page 113 - Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results, II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering.
Page 291 - Kagan A.: Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.
Page 73 - I am a partner in the Washington, DC law firm of Covington & Burling. I have been asked to present testimony on patent term restoration.
Page 341 - Five-year findings of the Hypertension Detection and Followup Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension.
Page 244 - For the purposes of paragraph (2)(B), the term "due diligence" means that degree of attention, continuous directed effort, and timeliness as may reasonably be expected from, and are ordinarily exercised by, a person during a regulatory review period.
Page 67 - HL-07182 from the National Heart, Lung and Blood Institute of the National Institutes of Health, and by the American Heart Association, Indiana Affiliate, Inc.
Page 8 - Mr. BOUCHER. Thank you very much, Mr. Chairman. I want to commend you...